Crossmark

Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy

Crossref DOI link: https://doi.org/10.1007/s13311-021-01093-8

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cetinkaya-Fisgin, Aysel

Zhu, Jing

Luan, Xinghua

Kim, Jun-Soon

Oh, Byoungchol

Brayton, Cory

Alt, Jesse

Rais, Rana

Slusher, Barbara

Höke, Ahmet https://orcid.org/0000-0003-1215-3373
Funding

Funding for this research was provided by:

National Institute of Neurological Disorders and Stroke (NS091260)

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (119309)
License Information

Text and Data Mining valid from 2021-07-01

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-021-01093-8

Content Type: article

Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.